Otsuka Pakistan Limited (PSX:OTSU)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
188.81
-1.32 (-0.69%)
At close: Mar 24, 2025
43.75%
Market Cap 2.20B
Revenue (ttm) 3.37B
Net Income (ttm) 4.10M
Shares Out 12.10M
EPS (ttm) 0.34
PE Ratio 538.33
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 213
Average Volume 2,470
Open 196.00
Previous Close 190.13
Day's Range 185.02 - 196.00
52-Week Range 105.05 - 235.98
Beta 0.26
RSI 42.46
Earnings Date Apr 25, 2025

About Otsuka Pakistan

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, and proten gold; and therapeutic drugs, w... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1988
Employees 345
Stock Exchange Pakistan Stock Exchange
Ticker Symbol OTSU
Full Company Profile

Financial Performance

In 2024, Otsuka Pakistan's revenue was 3.16 billion, an increase of 4.24% compared to the previous year's 3.04 billion. Losses were -4.76 million, -33.91% less than in 2023.

Financial Statements

News

There is no news available yet.